AAAAAA

   
Results: 1-10 |
Results: 10
LACK OF EFFECT OF MIZOLASTINE ON THE SAFETY AND PHARMACOKINETICS OF DIGOXIN ADMINISTERED ORALLY IN REPEATED DOSES TO HEALTHY-VOLUNTEERS
Authors: CHAUFOUR S LECOZ F DENOLLE T DUBRUC C CIMAROSTI I DESCHAMPS C ULLIAC N DELHOTALLANDES B ROSENZWEIG P
Citation: S. Chaufour et al., LACK OF EFFECT OF MIZOLASTINE ON THE SAFETY AND PHARMACOKINETICS OF DIGOXIN ADMINISTERED ORALLY IN REPEATED DOSES TO HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 36(5), 1998, pp. 286-291
SAFETY AND PHARMACOKINETICS OF A SINGLE ORAL DOSE OF AMISULPRIDE IN HEALTHY ELDERLY VOLUNTEERS
Authors: HAMONVILCOT B CHAUFOUR S DESCHAMPS C CANAL M ZIELENIUK I AHTOY P CHRETIEN P ROSENZWEIG P NASR A PIETTE F
Citation: B. Hamonvilcot et al., SAFETY AND PHARMACOKINETICS OF A SINGLE ORAL DOSE OF AMISULPRIDE IN HEALTHY ELDERLY VOLUNTEERS, European Journal of Clinical Pharmacology, 54(5), 1998, pp. 405-409
INTERACTION STUDY BETWEEN MIZOLASTINE, A NEW H-1 ANTIHISTAMINE, AND ERYTHROMYCIN
Authors: CHAUFOUR S HOLT B JENSEN R DUBRUC C DESCHAMP C ROSENZWEIG P
Citation: S. Chaufour et al., INTERACTION STUDY BETWEEN MIZOLASTINE, A NEW H-1 ANTIHISTAMINE, AND ERYTHROMYCIN, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 28-28
METABOLIC INTERACTION STUDIES OF MIZOLASTINE WITH KETOCONAZOLE AND ERYTHROMYCIN IN RAT, DOG AND MAN
Authors: DUBRUC C GILLET G CHAUFOUR S HOLT B JENSEN R MAUREL P THENOT JP
Citation: C. Dubruc et al., METABOLIC INTERACTION STUDIES OF MIZOLASTINE WITH KETOCONAZOLE AND ERYTHROMYCIN IN RAT, DOG AND MAN, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 85-85
SMALL STRESS PROTEINS MODULATORS OF APOPT OSIS
Authors: ARRIGO AP MEHLEN P PREVILLE X CHAUFOUR S KRETZREMY C GONIN S DIAZLATAUD C
Citation: Ap. Arrigo et al., SMALL STRESS PROTEINS MODULATORS OF APOPT OSIS, MS. Medecine sciences, 13(5), 1997, pp. 740-741
TRANSIENT ACCUMULATION, PHOSPHORYLATION AND CHANGES IN THE OLIGOMERIZATION OF HSP27 DURING RETINOIC ACID-INDUCED DIFFERENTIATION OF HL-60 CELLS - POSSIBLE ROLE IN THE CONTROL OF CELLULAR GROWTH AND DIFFERENTIATION
Authors: CHAUFOUR S MEHLEN P ARRIGO AP
Citation: S. Chaufour et al., TRANSIENT ACCUMULATION, PHOSPHORYLATION AND CHANGES IN THE OLIGOMERIZATION OF HSP27 DURING RETINOIC ACID-INDUCED DIFFERENTIATION OF HL-60 CELLS - POSSIBLE ROLE IN THE CONTROL OF CELLULAR GROWTH AND DIFFERENTIATION, Cell stress & chaperones, 1(4), 1996, pp. 225-235
COMPARATIVE WHEAL AND FLARE STUDY OF MIZOLASTINE VS TERFENADINE, CETIRIZINE, LORATADINE AND PLACEBO IN HEALTHY-VOLUNTEERS
Authors: ROSENZWEIG P CAPLAIN H CHAUFOUR S ULLIAC N CABANIS MJ THEBAULT JJ
Citation: P. Rosenzweig et al., COMPARATIVE WHEAL AND FLARE STUDY OF MIZOLASTINE VS TERFENADINE, CETIRIZINE, LORATADINE AND PLACEBO IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 40(5), 1995, pp. 459-465
ORAL LINTOPRIDE INCREASES BASAL LOWER ESOPHAGEAL SPHINCTER PRESSURE (LESP) IN HEALTHY-SUBJECTS
Authors: CHAUFOUR S VARANNES SBD ATLAN P CABANIS MJ LAVANANT C GALMICHE JP
Citation: S. Chaufour et al., ORAL LINTOPRIDE INCREASES BASAL LOWER ESOPHAGEAL SPHINCTER PRESSURE (LESP) IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 174-174
ORAL LINTOPRIDE INCREASES BASAL LOWER ESOPHAGEAL SPHINCTER PRESSURE IN HEALTHY SUBJECT
Authors: DESVARANNES SLB CHAUFOUR S ATLAN P LAVANANT C GALMICHE JP
Citation: Slb. Desvarannes et al., ORAL LINTOPRIDE INCREASES BASAL LOWER ESOPHAGEAL SPHINCTER PRESSURE IN HEALTHY SUBJECT, Gastroenterology, 106(4), 1994, pp. 10000472-10000472
PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS INFLUENCE OF EXPERIMENTAL CONDITIONS ON PHYSIOLOGICAL-PARAMETERS DURING PHASE 1 STUDIES
Authors: ROSENZWEIG P BROHIER S PINQUIER JL BERGOUGNAN L PALAT A CHAUFOUR S ZIPFEL A
Citation: P. Rosenzweig et al., PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS INFLUENCE OF EXPERIMENTAL CONDITIONS ON PHYSIOLOGICAL-PARAMETERS DURING PHASE 1 STUDIES, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 156-156
Risultati: 1-10 |